and sell before facing trials. Should we have empathy for Bayer that has made a very bad purchase ?
That's why the defence has focused so far on facts and studies.
(Note: I'm not saying one is better than the other. Just that the risk was probably assessed with assumptions that turned out to be incorrect.)